Changes in Syndecan-1 During Tumor Progression in Colonic Cells
Author Information
Author(s): P Levy, A Munier, S Baron-Delagel, Y Di Gioia, C Gespach, J Capeau, G Cherqui
Primary Institution: INSERM-U.402, Faculte de Medecine Saint-Antoine, Paris, France
Hypothesis
The study aims to determine if tumorigenic progression in Caco-2 cells induced by oncogenes is associated with specific alterations of syndecan-1.
Conclusion
The study found that oncogenic activation of Caco-2 cells leads to significant changes in syndecan-1 expression and its ectodomain characteristics.
Supporting Evidence
- Oncogene-transfected Caco-2 cells showed decreased syndecan-1 protein expression without changes in mRNA levels.
- Alterations in syndecan-1 ectodomain included reduced glycosaminoglycan chain length and sulphation.
- Both oncogenes induced similar changes in syndecan-1 expression, suggesting a common pathway in tumorigenesis.
Takeaway
When certain genes that cause cancer are activated in colon cells, the way these cells express a protein called syndecan-1 changes, which might affect how they grow and spread.
Methodology
Caco-2 cells were transfected with oncogenes and analyzed for syndecan-1 expression and ectodomain characteristics using biochemical assays.
Want to read the original?
Access the complete publication on the publisher's website